 |
ublituximab |
|---|---|
| Trade Name | |
| Orphan Indication | Neuromyelitis optica |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-25 00:00:00 |
| Sponsor | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 |
| |
ublituximab |
|---|---|
| Trade Name | |
| Orphan Indication | Neuromyelitis optica |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-25 00:00:00 |
| Sponsor | TG Therapeutics, Inc.;3 Columbus Circle, 15th Floor;New York, New York, 10019 |